Fangzhou Inc. (06086.HK), a prominent Internet healthcare solution provider, distinguished itself as the exclusive digital health innovator invited to the Modern Industrial System Development Summit, convened by the Guangzhou Industrial Development Research Institute on April 1, 2025. This closed-door forum brought together executives from leading entities such as Alibaba and Baidu, alongside representatives from academia and government agencies, to strategize on positioning Guangzhou as a national frontrunner in domain-specific large language AI models, a critical element of China's "new quality productive forces."

Dr. Xie Fangmin, the founder, chairman, and CEO of Fangzhou, emphasized the company's commitment to advancing domain-specific AI models capable of addressing real-world healthcare challenges while upholding the highest standards of safety and efficacy. Fangzhou's dedication to innovation and responsible AI implementation was a focal point of their participation in the summit.

At the summit, Fangzhou unveiled its groundbreaking approach to ensuring medical AI accuracy and reliability through an innovative three-tiered safety system. This security framework leverages a "robust knowledge database + multi-model collaboration + stringent safety controls," aiming to reduce hallucinations and mitigate risks by ensuring data source integrity, optimizing model training, and validating outputs. This comprehensive safety architecture is designed to address critical risks such as flawed symptom assessments or false drug information, ensuring the integrity of AI-driven healthcare solutions.

Fangzhou proposed a two-tiered approach to accelerate Guangzhou's development of domain-specific AI expertise. This strategy encompasses both R&D and industry deployment, with specific recommendations for each. For R&D, Fangzhou advocated for strengthening interdisciplinary talent development in medical AI, fostering high-impact use cases, and accelerating technology commercialization. In terms of industry deployment, the strategy focuses on bolstering infrastructure, emphasizing practical use cases, and fostering ecosystems, with targeted support for specialized and innovative companies.

Fangzhou's expansion plans are intricately linked to its implementation of advanced AI models like DeepSeek-V3 and strategic collaborations with Tencent Health and Tencent Cloud. These collaborations aim to advance AI-enabled healthcare solutions, enhance technological strength, and accelerate the commercialization of innovations. The ultimate goal is to provide enhanced experiences for both patients and users through AI-powered healthcare solutions.

Fangzhou Inc. (06086.HK) stands as China's leading online chronic disease management platform, boasting 49.2 million registered users and a network of 223,000 physicians as of December 31, 2024. The company specializes in delivering tailored medical care and precision medicine solutions, leveraging its extensive platform and AI capabilities to improve healthcare outcomes.

The Modern Industrial System Development Summit aims to establish Guangzhou as a hub for strategic sectors like AI and biotech by 2025. Vertical-specific models are prioritized under China's 2024 State Council AI guidelines to counter "homogeneous competition" in generic AI, highlighting the strategic importance of domain-specific AI development.

For media inquiries, contact Xingwei Zhao, Associate Director of Public Relations, at [email protected]